Pentagon ordered to study menopause gap in military medicine

What it does

This bill directs the Department of Defense and Veterans Affairs to evaluate existing research on menopause and mid-life women's health among servicewomen and female veterans, identify gaps in knowledge (including effects of combat exposure, burn pits, and PFAS), and submit a report with recommendations and a strategic research plan within 180 days. It also expresses Congress's sense that these agencies should conduct additional research on menopause-related treatments and their impact on military women.

Why we flagged it

The bill is a straightforward mandate for federal agencies to evaluate and plan research on a specific health condition affecting a defined population (servicewomen and female veterans). It contains no tax provisions, subsidies, or regulatory carve-outs—only research evaluation and reporting requirements.

What the text implies

• The bill's focus on service-related menopause impacts (burn pits, PFAS, combat roles) may establish a precedent for recognizing menopause-related conditions as service-connected disabilities, potentially expanding VA benefits eligibility.
• Requiring evaluation of 'uptake of treatments' and 'availability' may implicitly pressure DoD and VA to expand access to hormone replacement therapy and other menopause treatments in military healthcare systems.
• The 180-day reporting deadline is tight; agencies may produce high-level summaries rather than comprehensive research, limiting the strategic plan's depth.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill directs federal agencies to study a significant health gap affecting servicewomen and female veterans—menopause and mid-life health—and to improve training for military healthcare providers. This addresses a documented underserving of women's health in military medicine and may lead to better treatment access and understanding of service-related health impacts for this population.

Named in the bill

Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, Servicewomen, Female veterans

Where it stands

25 cosponsors: 21 Democrats, 4 Republicans.

• Apr 8, 2025 — Introduced · Congress.gov: “Introduced in House”
• Apr 8, 2025 — Referred to House Committee on Veterans' Affairs and House Committee on Armed Services · Congress.gov: “Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,296,355 in lobbying spend. A filing names 57 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Chrissy Houlahan, the sponsor, reported $539,500 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,715,904 on 2 filings
• Disabled American Veterans — $310,451 on 2 filings
• Hadassah, the Women's Zionist Organization of America, Inc. — $120,000 on 2 filings
• Iraq and Afghanistan Veterans of America Inc — $120,000 on 1 filing
• Wounded Warrior Project — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.